Cardiac Surgery ICU, OCSC, Athens, Greece.
Heart Failure Unit, OCSC, Athens, Greece.
Perfusion. 2024 Sep;39(6):1259-1264. doi: 10.1177/02676591231181847. Epub 2023 Jun 5.
Pulmonary hemorrhage is a life-threatening complication of VA-ECMO occasionally presenting with Harlequin syndrome.
We present a case of a VA-ECMO patient complicated with pulmonary hemorrhage, complete right lung atelectasis and differential hypoxia refractory to conventional treatment including optimal mechanical ventilation and bronchoscopy interventions. Patient was successfully managed by conversion of VA to VAV-ECMO.
Pulmonary hemorrhage and atelectasis treatment in a VA-ECMO patient includes transfusion, hold and reversal of anticoagulation, bronchoscopy interventions and optimization of VA-ECMO and ventilator support. Differential hypoxia may ensue due to residual native cardiac function. If refractory to conservative treatment, a VAV-ECMO configuration may be utilized to improve upper body oxygenation by inserting an additional cannula to the superior vena cava.
VAV-ECMO is an ECMO configuration support in patients at risk of Harlequin syndrome presenting with pulmonary hemorrhage.
肺出血是 VA-ECMO 的一种危及生命的并发症,偶尔会出现 Harlequin 综合征。
我们报告了一例 VA-ECMO 患者并发肺出血、完全性右肺不张和对常规治疗(包括最佳机械通气和支气管镜介入治疗)无反应的缺氧。患者通过将 VA 转换为 VAV-ECMO 成功得到治疗。
VA-ECMO 患者的肺出血和肺不张治疗包括输血、停止和逆转抗凝、支气管镜介入治疗以及优化 VA-ECMO 和呼吸机支持。由于残留的原生心脏功能,可能会出现缺氧。如果对保守治疗无反应,可能需要使用 VAV-ECMO 配置,通过向上腔静脉插入额外的插管来改善上半身的氧合。
VAV-ECMO 是一种 ECMO 配置支持,适用于有发生 Harlequin 综合征风险并出现肺出血的患者。